Elsevier

Biochemical Pharmacology

Volume 37, Issue 20, 15 October 1988, Pages 3959-3966
Biochemical Pharmacology

Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets

https://doi.org/10.1016/0006-2952(88)90080-9Get rights and content

Abstract

Chemical modification procedures have been used to study the interaction of tricyclic and non-tricyclic 5HT-reuptake inhibitors with the [3]imipramine binding site (IBS). N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) induced a pronounced loss in [3H]imipramine binding due to a reduction in Bmax. Preincubation with reuptake inhibitors and subsequent inactivation by EEDQ revealed that imipramine and 5HT prevented the EEDQ-induced inhibition, but citalopram and fluoxetine did not. Thiol modification studies demonstrated that reduction by dithiothreitol (DTT) enhanced the binding of [3H]imipramine by increasing the Bmax. The thioselective reagents 1,1-diazobis- (N,N-dimethylformamide) (diamide), phenyl-arsineoxide (PAO) and N-ethylmaleimide (NEM) attenuated the binding capacity by lowering the Bmax. PAO, a reversible thiol reagent, prevented NEM alkylation indicating that dithiols are involved in the NEM-induced inactivation. Binding of tricyclics or non-tricyclics prior to PAO inactivation revealed that tricyclics provide complete protection against thiol modification, while the non-tricyclics do not. The results support the hypothesis that the 5HT-reuptake system of human platelets possesses at least two distinguishable binding sites.

Cited by (26)

  • Synthesis and inhibitory evaluation of 3-linked imipramines for the exploration of the S2 site of the human serotonin transporter

    2016, Bioorganic and Medicinal Chemistry
    Citation Excerpt :

    Previously, we also observed that imipramine docked into the S2 site was orientated with the alkyl amine pointing towards the central S1 binding site.9 Several antidepressants have been shown to also possess allosteric properties,39,40 and it has been suggested that they exert their effect by binding to a vestibular site located above the S1 site.20 We hypothesized that a ligand utilizing both sites with a linker of the appropriate length could have improved potency and selectivity.

View all citing articles on Scopus
View full text